Follow Us

       


"Like" us on Facebook

Clinical Trials

Disease or Condition
Cancer - Multiple Myeloma
Title
Denosumab Compared to Zoledronic Acid in the Treatment of Bone Disease in Subjects With Multiple Myeloma
Description
A Randomized, Double-Blinded, Multicenter Study of Denosumab Compared With Zoledronic Acid (Zometa) in the Treatment of Bone Disease in Subjects with Newly Diagnosed Multiple Myeloma (20090482)
IRB Number
NCT01345019
Inclusion/Notes

Please contact the research department for full eligibility information. For additional information, please click here:http://clinicaltrials.gov/ct2/show/NCT01345019 http://www.clinicaltrials.gov/ct2/results?term=NCT01345019&Search=Search

Status
Open to Enrollment
Principal Investigator
Frederic C. Kass, MD
Contact Email
research@ccsb.org
Phone
(805) 898-2117

This is the fat footer - edit page 906 to add content.